A series of triazolophthalazine derivatives (4-22) were synthesized and characterized. The structures of the newly synthesized compounds were confirmed by spectral data. The newly synthesized compounds were also screened for their antimicrobial activity.
Introduction
Reports of the synthesis of phthalazine-1(H)-one derivative have been recently published [1] [2] [3] [4] [5] [6] [7] [8] [9] . Phthalazine derivatives are important heterocyclic and are known to possess variety of biological activities such as antimicrobial, anticonvulsant, cardiotonic, vasorelaxant, antifungal, anticancer, antitumor agent, antianxiety drug, and anti-inflammatory activities [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . Multiple reports indicates that arylaminophthalazine derivative ( Figure 1 , A) act as inhibitor of vascular endothelial growth factor (VEGFR-2) has entered clinical testing against various cancers [20] . Also, a series of 1-(isoquinoline-5-yl)-4-arylaminophthalazine ( Figure 1 , B) were studied as a potent inhibitors of VEGFR and the later compound inhibit VEGFR-1, a related receptor tyrosine kinase [21, 22] . γ-Aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the brain [23] .
3-Phenyl-6-(pyrid-2-ylmethloxy)- [1, 2, 4] triazolo[3,4-a] phthalazine (Figure 1 , C) was identified as a class of GABA-A receptor ligands with large improvement in binding affinity due to hydrogen-bond-donating interaction from the receptor adjacent to that portion of the molecule [24] (Figure 1, C) .
In view of the above aforementioned facts, the author, undertook synthesis of some newly benzo-fused ring of 4-benzylphthalazine, such derivatives could possess interesting and useful biological properties.
Experimental

Instrumentation
Melting points were determined on a Stuart melting point apparatus and are uncorrected. IR spectra were recorded in KBr using a FT-IR 5300 spectrometer and Perkin Elmer spectrum RXIFT-IR system (ν, cm −1 ). The 1 H NMR at 300 MHz and 13 C NMR spectra at 75 MHz were recorded in DMSO-d6 on a Varian Mercury VX-300 NMR spectrometer. Chemical shifts (δ) are related to that of the solvent. Mass spectra were measured on a Shimadzu GC-MS-QP-1000 EX mass spectrometer at 70 eV. The elemental analyses were performed at the Microanalytical Center, Cairo University, Cairo, Egypt. 
General procedure for the synthesis of 4-benzylphthalazine derivatives (2 and 3)
A mixture of 4-benzyl-1-chlorophthalazine (1) (0.25 g, 10 mmol) and thiosemicarbazide or thiocarbohydrazide (10 mmol) in absolute ethanol (30 mL) was refluxed for 3 hours. The solvent was evaporated in vacuum. The obtained solid was filtered off and washed with ethanol (Scheme 1). 
General procedure for the synthesis of triazolophthalazine derivatives (4 and 5)
A mixture of 4-benzyl-1-chlorophthalazine (1) (0.25 g, 10 mmol) and (4-benzyl-1-oxo-1H-phthalazin-2yl)acetic acid hydrazide (0.30 g, 10 mmol) or cyanoacetohydrazide (0.09 g, 10 mmol) in absolute ethanol (30 mL) and 2 drops of TEA was refluxed for 3 hours. The solvent was evaporated in vacuum. The obtained solid was filtered off and washed with ethanol (Scheme 1 and 2). [1, 2, 4] triazolo [3,4-a] 
4-Benzyl-2-((6-benzyl
General procedure for the synthesis of triazolophthalazineacrylonitrile derivatives (6a-d)
A mixture of (6-benzyl [1, 2, 4] triazolo [3,4-a] phthalazin-3-yl)aceto-nitrile (5) (0.29 g, 10 mmol) and aromatic aldehydes (10 mmol) in absolute ethanol (30 mL) and 2 drops of piperidine was refluxed for 2 hours. The solvent was evaporated in vacuum. The obtained solid was filtered off and washed with ethanol (Scheme 2).
2-(6-Benzyl [1, 2, 4] triazolo [3,4-a] 
General procedure for the synthesis of triazolophthalazinechromene derivatives (7-10)
A mixture of (6-benzyl [1, 2, 4] triazolo [3,4-a] phthalazin-3-yl)acetonitrile (5) (0.29 g, 10 mmol) and phenolic aldehydes (salicylaldehyde, 2-hydroxy-1-naphthaldehyde and 2,7-dihydroxy-1-naphthaldehyde) (10 mmol) in absolute ethanol (30 mL) and 2 drops of piperidine was refluxed for 2 hours. The obtained solid was filtered off and washed with ethanol (Scheme 3).
3-(6-Benzyl [1, 2, 4] triazolo [3,4-a] [1, 2, 4] triazolo [3,4- 
2-(6-Benzyl
a]phthalazin-3-yl)-3-imino- 3H-benzo[f]chromen-9-ol (9b):
2-(6-Benzyl[1,2,4]triazolo[3,4-a]phthalazin-3-yl)-benzo[f] chromen-3-one
General procedure for the synthesis of phthalazinehydrazo acetonitrile derivatives (11 and 12)
To a stirred solution of (6-benzyl [1, 2, 4] triazolo [3,4-a] phthalazin-3-yl)acetonitrile (5) (0.29 g, 10 mmol) in ethanol (50 mL) containing, sodium acetate (3 g) p-tolyldiazonium salt or triazolediazonium salt (prepared by adding sodium nitrite (10 mmol) to p-toluidine (0.12 g, 10 mmol) or 1,2,4-triazol-3-amine (0.13 g, 10 mmol) in conc. HCl (6 mL) at 0~5 o C under stirring was added dropwise The reaction mixture was then left at room temperature for 2 hours. and the solid product formed was collected by filtration (Scheme 4). ( 
6-Benzyl-N'-(p-tolyl)-[1,2,4]triazolo[3,4-a]phthalazine-3-carbohydrazonoyl cyanide
Synthesis of 2-(6-benzyl[1,2,4]triazolo[3,4-a]phthalazin-3-yl)-3-ethoxyacrylonitrile (13)
A mixture of (6-benzyl [1, 2, 4] 
General procedure for the synthesis of triazolophthalzine derivatives (14 and 15)
A mixture of 2-(6-benzyl [1, 2, 4] triazolo [3,4-a] phthalazin-3-yl)-3-ethoxyacrylonitrile (13) (10 mmol) and NH2OH . HCl (15 m mol) or NH2CSNH2 (10 mmol) in ethanol (30 mL) fused sodium acetate (25 mmol) was added. The resulting mixture was refluxed for 3 hrs and then allowed at cool to room temperature and diluted with water (20 mL). The obtained solid was filtered off and washed with ethanol (Scheme 5).
3-Amino-2-(6-benzyl [1, 2, 4] triazolo [3,4-a] A mixture of (6-benzyl [1, 2, 4] triazolo[3,4-a]phthalazin-3-yl)acetonitrile (13) (10 mmol) and thioglycolic acid (10 mmol) in pyridine (10 mL) was refluxed for 3 hours. The solvent was removed on rotary evaporation the solid obtained was filtered off, washed with ethanol. Gray crystals. Crystallization from dioxane (Scheme 7 
Synthesis of 2-((6-benzyl-[1,2,4]triazolo[3,4-a] phthalazin-3-yl)methyl)-5-(4-methoxybenzylidene)thiazol-4-one (20)
A mixture of 2-(6-benzyl[1,2,4]triazolo[3,4-a]phthalazin-3-ylmeth-yl)thiazolidin-4-one (19) (10 mmol) and p-anisaldehyde (10 mmol) in ethanol (20 mL) and few drops of piperidine was refluxed for 3 hours. The mixture then cooled and the separated solid was filtered off washed with ethanol. Yellow crystals. Crystallization from dioxane (Scheme 7 
Synthesis of 2-((6-benzyl-[1,2,4]triazolo[3,4-a] phthalazin-3-yl)methyl)-7-(4-methoxyphenyl)-5-oxo-6,7-dihydro-5H-pyrano[2,3-d]thiazole-6-carbonitrile (21)
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Synthesis of 5-amino-8-(6-benzyl-[1,2,4]triazolo[3,4-a]phthalazin-3-yl)-2-(4-methylbenzylidene)-3-oxo-7-(p-tolyl)-3,7-dihydro-2H-thiazolo[3,2-a]pyridine-6-carbonitrile (22)
A
Antimicrobial assay
The antimicrobial activity of the newly synthesized compounds 2-22 were evaluated against two species of Gramnegative bacteria Pseudomonas aeruginosa (MTCC 741) and Escherichia coli (NCTC-10410); four Gram-positive bacteria, Bacillus cereus (ATGG 14579), Bacillus subtilis (MTCC 441), Bacillus sphaericus (MTCC 11) and Staphylococcus (MTCC 96); and two fungus, Aspergillus ochraceus Wilhelm (AUCC-230) and Penicillium chrysogenum Thom (AUCC-530) strains by disk diffusion method. Ampicillin and Mycostatin were used as standard drugs for the bacteria and fungi, respectively [27, 28] . Preliminary screening of phthalazine derivatives and standard drugs was performed at fixed concentrations of 500 μg/mL. Inhibition was recorded by measuring the diameter of the inhibition zone at the end of 24 h for bacteria and 72 h for fungi. Each experiment was repeated twice. Based on the results of zone of inhibition, the minimum inhibitory concentration (MIC) of compounds 2-22 against all bacterial and fungal strains was determined by liquid dilution method. Stock solutions of tested compounds with 500, 250, 200, 100, 50, 25, 12.5, and 6.25 μg/mL concentrations were prepared with DMSO solvent. The solutions of standard drugs, Ampicillin and Mycostatin are used in the same concentrations. Inoculums of the bacterial and fungal culture were also prepared. To a series of tubes containing 1 mL each of phthalazine compound solution with different concentrations and 0.2 mL of the inoculums was added. Further 3.8 mL of sterile water was added to each of the test tubes. These test tubes were incubated for 24 h at 37 o C and observed for the presence of turbidity. This method was repeated by changing phthalazine compounds with standard drugs Ampicillin and Mycostatin for comparison. The minimum inhibitory concentration at which no growth was observed was taken as the MIC value (Table 1) .
Results and discussion
Synthesis
Treatment of 4-benzyl-1-chlorophthalazine (1) [25] with thiosemicarbazide furnished 4-benzylphthalazin-1-ylthiol (2).
While interaction of compound 1 with thiocarbohydrazide, 4-benzylphthalazin-1-ylamine (3) was the only isolable product. The formation of these products 2 and 3 pointed out that the less negative atom (S in case of thiosemicarbazide and terminal N in case of thiocarohydrazide) attacks the electrophilic carbon attached to Cl and = N groups (Scheme 1).
Interaction of (4-benzyl-1-oxo-1H-phthalazin-2-yl)acetic acid hydrazide [26] with compound 1 afforded the corresponding 4-benzyl-2-((6-benzyl[1,2,4]-triazolo-[3,4-a]phthalazin-3-yl)methyl)phthalazin-1(2H)-one (4) (Scheme 1).
The structure of compounds 2-4 were confirmed by IR, 1 H NMR, 13 C NMR and MS. The IR spectra of compound 2 showed ν at 2908 cm -1 (SH), for compound 3 showed ν at 3274, 3204 cm -1 (NH2), 1640 cm -1 (C=N), respectively. 1 H NMR spectra of compound 2 showed δ at 8.61 (brs, 1H, NH), 14.32 (s, 1H, SH), for compound 3 showed δ at 4.48 (brs, 2H, NH2), for compound 4 indicates that its structure is a mixture of three tautomeric forms (A) , (B) and (C) in different contributions showed δ at 11.14, 11.35 (2s, 1H, NH), 10.13, 9.93 (2s, 1H, NH), respectively. 13 The structure of compounds 7-10 were confirmed by IR, 1 H NMR and MS. The IR spectra of compound 7 showed ν at 3228 cm -1 (NH), for compound 8 showed ν at 1732 cm -1 (CO), for compound 9b showed ν at 3280 cm -1 (NH), 3476 cm -1 (OH), for compound 10a showed ν at 1726 cm -1 (CO), compound 10b showed ν at 3452 cm -1 (OH), 1720 cm -1 (CO). 1 The structure of compounds 11 and 12 were confirmed by IR, 1 H NMR and MS. The IR spectra of compound 11 showed ν at 3082 cm -1 (NH), 2220 cm -1 (CN), for compound 12 showed ν at 3076 cm -1 (NH, br), 2224 cm -1 (CN), respectively. 1 H-NMR spectra of compound 12 showed δ at 14.00, 13.60 (s, 2H, NH), 12.60 (s, 1H, triazolo-H). The mass spectra of compounds 11 and 12 and showed the corresponding molecular ion peaks at m/z = 417 (M + , 13.1), m/z = 394 (M + , 61.9), respectively.
Reaction of compound 5 with triethyl-orthoformate in boiling acetic anhydride to give 2-(6-benzyl [1, 2, 4] triazolo [3,4-a] phthalazin-3-yl)-3-ethoxyacrylonitrile (13) and treatment of compound 13 with hydroxylamine hydrochloride in boiling ethanol-fused sodium acetate gave 3-amino-2-(6-benzyl [1, 2, 4] triazolo [3,4-a] phthalazin-3-yl)-3-(hydroxyimino)prop-1-enyl acetate (14) . The formation of compound 14 can be attributed to the nucleophilic addition of NH2OH to the CN group and nucleophilic exchange of the ethoxy group by the acetoxy nucleophile. Compound 13 undergoes cycloaddition with thiourea to furnished the corresponding 4-amino-5-(6-benz-yl [1, 2, 4] Treatment of 3-ethoxyacrylonitrile derivative (13) with hydrazine hydrate in ethanol at room temperature was unsuccessful, while when under reflux, the reaction was successful and the reaction product was identified as ethyl 3-amino-2-(6-benzyl [1, 2, 4] triazolo [3,4-a] phthalazin-3-yl)-3-hydrazonopropane hydrazonate (17) .
The formation of such compound indicated that the reaction proceeds through nucleophilic addition of two hydrazine molecules to the vinyl and the nitrile groups leading to the formation of non-isolable intermediate (A), which in turn, undergoes spontaneous dehydrogenation rather than elimination of ethanol molecule to give compound 17 as the only isolable product (Scheme 6).
Also, treatment of compound 13 with ethanolic phenylhydrazine under the conditions of reflux gave the isolable product which was identified as 2-(6-benzyl- [1, 2, 4] triazolo [3,4-a] phthalazin-3-yl)-3-ethoxy-3-(2-phenyl hydrazinyl)acrylonitrile (18) . The formation of this product could be explained through nucleophilic addition of one phenylhydrazine molecule to vinyl group followed by oxidation of the intermediate (B) to the final product (Scheme 6).
The structure of compounds 17 and 18 were confirmed by IR and MS. The IR spectrum of compound 17 showed absorptions at 3198 cm −1 (NH), 1598 cm −1 (C=N), while for compound 18 showed absorptions at 3212 (NH), 2198 cm −1 (CN). The mass spectra of compounds 17 and 18 showed the corresponding molecular ion peaks m/z (%): 417 (M + , 32.6) and 461 (M + , 100), respectively.
Treatment of compound 5 with thioglycolic acid, the given reaction in Scheme 7 would occur, where 2-(6-benzyl [1, 2, 4] triazolo [3,4- (22) . The formation of compound 22 is rationalized by the condensation of two molecules of aromatic aldehyde with 4-thiazolinone and malononitrile, respectively followed by the nucleophilic addition of methylene bridge of the 1 st derivative to the activated ethylenic double bond of the second one and the formed adduct (B) undergoes intramolecular cyclization into the final product 22 (Scheme 8).
The structure of compounds 21 and 22 were confirmed by IR, 1 
Antimicrobial activity
The antimicrobial activity of the newly synthesized compounds 2-22 were evaluated against two species of 
Conclusion
Our interest in synthesis of heterocyclic compounds is to focus on their antimicrobial activity as a part of our program which aimed at the development of new and more potent antimicrobial agents. Thus, in this paper, we revealed the synthesis of some triazolophthalazine derivatives and antimicrobial evaluation of all the novel compounds. The structures of the novel compounds were elucidated on the basis of IR, 1 H NMR, 13 C NMR and MS data. A series of novel triazolophthalazine derivatives were prepared. The antimicrobial activity of these compounds was evaluated against various Gram-positive, Gram-negative bacteria and fungi. Triazolophthalazine and triazolophthalazinethiazole derivatives are strong activities against any of the test microorganisms.
